Vega Economics

Analysis of Price Fixing and Market Allocation for Certain Generic Drugs

Retained by Robbins Geller

Dr. Andrew Zuppann of Vega Economics was retained by a group of pension funds as opt-out plaintiffs in a securities case to analyze issues related to a pharmaceutical company's alleged price fixing and market allocation scheme for certain generic drugs.

Looking for an expert?

We will help you find the right expert for your matter.

Vega Economics

Vega Economics provides rigorous economic analysis and expert testimony to help law firms and corporations solve their most complex challenges.

Contact

Menu

© 2026 Vega Economics. All rights reserved.
Privacy Policy

We use cookies to improve your experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to our use of cookies. See our Privacy Policy to learn more.